As COVID-19 reshapes our economy, our newsletter will help you unpack the news from the day.
More generics are needed to create competition — but can the FDA approve them fast enough?
New guidelines on the use of statins to lower cholesterol hold the promise to dramatically increase the number of Americans who take those drugs.
OxyContin is supposed to come off patent and generic drug makers are excited. But, the FDA may put a stop to it all to wait for safer pills.
India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.
The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drug makers can be held liable for alleged flaws in the designs of their medications.